AU2002343103A1 - Aminoalkylimidazole derivatives and their use in medicine - Google Patents

Aminoalkylimidazole derivatives and their use in medicine

Info

Publication number
AU2002343103A1
AU2002343103A1 AU2002343103A AU2002343103A AU2002343103A1 AU 2002343103 A1 AU2002343103 A1 AU 2002343103A1 AU 2002343103 A AU2002343103 A AU 2002343103A AU 2002343103 A AU2002343103 A AU 2002343103A AU 2002343103 A1 AU2002343103 A1 AU 2002343103A1
Authority
AU
Australia
Prior art keywords
aminoalkylimidazole
medicine
derivatives
aminoalkylimidazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002343103A
Inventor
Claes Bavik
Michael Cork
Gordon Duff
Joe Harrity
Rachid Tazi-Ahnini
Simon Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Skincare Ltd
Original Assignee
Molecular Skincare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Skincare Ltd filed Critical Molecular Skincare Ltd
Publication of AU2002343103A1 publication Critical patent/AU2002343103A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002343103A 2001-11-27 2002-11-27 Aminoalkylimidazole derivatives and their use in medicine Abandoned AU2002343103A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0128415.7 2001-11-27
GB0128415A GB0128415D0 (en) 2001-11-27 2001-11-27 Medicaments
PCT/GB2002/005329 WO2003045381A1 (en) 2001-11-27 2002-11-27 Aminoalkylimidazole derivatives and their use in medicine

Publications (1)

Publication Number Publication Date
AU2002343103A1 true AU2002343103A1 (en) 2003-06-10

Family

ID=9926551

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002343103A Abandoned AU2002343103A1 (en) 2001-11-27 2002-11-27 Aminoalkylimidazole derivatives and their use in medicine

Country Status (3)

Country Link
AU (1) AU2002343103A1 (en)
GB (1) GB0128415D0 (en)
WO (1) WO2003045381A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207637D0 (en) * 2002-04-02 2002-05-15 Karobio Ab Novel compound
WO2006032299A1 (en) * 2004-09-24 2006-03-30 Susanna Miettinen Use of inhibitors of 24-hydroxylase in the treatment of cancer
EP3095447B1 (en) 2006-02-03 2021-11-24 OPKO Renal, LLC Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PT2037936E (en) 2006-06-21 2014-09-04 Opko Renal Llc Method of treating and preventing secondary hyperparathyroidism
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
CN104523707B (en) 2007-04-25 2022-08-26 欧普科Ip 控股Ii 有限公司 Oral controlled release compositions comprising vitamin D compounds and waxy carriers
KR101685031B1 (en) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
NZ704666A (en) 2012-08-23 2018-05-25 Alios Biopharma Inc Compounds for the treatment of paramoxyvirus viral infections
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
EP3036220A4 (en) 2013-08-21 2017-04-12 Alios Biopharma, Inc. Antiviral compounds
CR20170085A (en) 2014-08-07 2017-04-25 Opko Ireland Global Holdings Ltd ADJUNCTIVE THERAPY WITH 25-HYDROXY VITAMIN D
KR20180123100A (en) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 How to Treat Vitamin D
CN109851560B (en) * 2019-01-09 2020-07-07 河南新天地药业股份有限公司 Biphenyl diazole derivative and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH677925A5 (en) * 1986-12-03 1991-07-15 Sandoz Ag
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment

Also Published As

Publication number Publication date
GB0128415D0 (en) 2002-01-16
WO2003045381A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
IL156678A0 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU7240201A (en) Aza- and polyazanthranyl amides and their use as medicaments
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002343103A1 (en) Aminoalkylimidazole derivatives and their use in medicine
AU2002247726A1 (en) 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof
AU2002358661A1 (en) Novel amidine derivatives and the use of the same in pharmaceuticals
AU6150400A (en) Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
AU2002237537A1 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
AU2002237536A1 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
AU2002234871A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase